Page 14 - Commodore Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Soleno Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters Option to Purchase Additional Shares

Soleno Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters Option to Purchase Additional Shares
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesBrian ritchieSoleno therapeutics incLaidlaw company united kingdom ltdFrazier life sciencesSyndicate prospectus departmentLifesci advisorsGuggenheim securitiesOppenheimer coCantor fitzgerald coEquity syndicate departmentExchange commissionTherapeutics announces closingUnderwritten public offeringCommon stock

Soleno Therapeutics Announces Pricing of Approximately $120 Million Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants

Soleno Therapeutics Announces Pricing of Approximately $120 Million Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesBrian ritchieSoleno therapeutics incExchange commissionCantor fitzgerald coOppenheimer coFrazier life sciencesSyndicate prospectus departmentGuggenheim securitiesLifesci advisorsSecurities exchangeLaidlaw company united kingdom ltdEquity syndicate departmentSoleno therapeuticsCapital partners

Commodore Capital LP Buys 112,889 Shares of Arrowhead Pharmaceuticals, Inc (NASDAQ:ARWR)

Commodore Capital LP lifted its stake in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 24.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 575,000 shares of the biotechnology company’s stock after purchasing an additional 112,889 shares during the quarter. […]

United statesPiper sandlerTracie oliverZurcher kantonalbank zurich cantonalbankArrowhead pharmaceuticals incArrowhead pharmaceuticals profileNews ratings for arrowhead pharmaceuticals dailyArrowhead pharmaceuticals stock performanceExchange commissionQuarter for arrowhead pharmaceuticalsUs bancorpPanagora asset management incTexas permanent school fund corpCantor fitzgeraldRoyal bankInsider activity at arrowhead pharmaceuticals

Commodore Capital LP Acquires 252,924 Shares of Akero Therapeutics, Inc (NASDAQ:AKRO)

Commodore Capital LP raised its holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 47.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 790,000 shares of the company’s stock after purchasing an additional 252,924 shares during the quarter. Akero Therapeutics accounts […]

New zealand generalNew zealandAndrew chengWilliam richard whiteJpmorgan chase coAlkeon capital managementPricet rowe associates incBlackrock incWellington management groupAkero therapeutics incCommodore capitalAkero therapeuticsFree reportPartners managementCapital managementManagement group

Viridian Therapeutics, Inc (NASDAQ:VRDN) Shares Bought by Commodore Capital LP

Commodore Capital LP boosted its position in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) by 8.4% in the 1st quarter, HoldingsChannel reports. The fund owned 2,189,659 shares of the company’s stock after acquiring an additional 169,493 shares during the period. Viridian Therapeutics accounts for about 8.5% of Commodore Capital LP’s portfolio, making the […]

Hood riverClara meisnerRenaissance technologiesKopp family officeHood river capital managementGhost tree capitalDeutsche bankSecurities exchange commissionViridian therapeutics company profileRoyal bankWells fargo companyViridian therapeutics incCommodore capitalViridian therapeuticsFree reportFamily office